Bryan Kwun-Chung Cheng , Steffi Kar-Kei Yuen , Daniele Castellani , Marcelo Langer Wroclawski , Hongda Zhao , Mallikarjuna Chiruvella , Wei-Jin Chua , Ho-Yee Tiong , Yiloren Tanidir , Jean de la Rosette , Enrique Rijo , Vincent Misrai , Amy Krambeck , Dean S. Elterman , Bhaskar K. Somani , Jeremy Yuen-Chun Teoh , Vineet Gauhar
{"title":"定义良性前列腺梗阻手术的微创手术治疗：来自全球知识、态度和实践调查的视角","authors":"Bryan Kwun-Chung Cheng , Steffi Kar-Kei Yuen , Daniele Castellani , Marcelo Langer Wroclawski , Hongda Zhao , Mallikarjuna Chiruvella , Wei-Jin Chua , Ho-Yee Tiong , Yiloren Tanidir , Jean de la Rosette , Enrique Rijo , Vincent Misrai , Amy Krambeck , Dean S. Elterman , Bhaskar K. Somani , Jeremy Yuen-Chun Teoh , Vineet Gauhar","doi":"10.1016/j.ajur.2022.02.011","DOIUrl":null,"url":null,"abstract":"<div><h3>Objective</h3><p>To scrutinize the definitions of minimal invasive surgical therapy (MIST) and to investigate urologists’ knowledge, attitudes, and practices for benign prostatic obstruction surgeries.</p></div><div><h3>Methods</h3><p>A 36-item survey was developed with a Delphi method. Questions on definitions of MIST and attitudes and practices of benign prostatic obstruction surgeries were included. Urologists were invited globally to complete the online survey. Consensus was achieved when more than or equal to 70% responses were “agree or strongly agree” and less than or equal to 15% responses were “disagree or strongly disagree” (consensus agree), or when more than or equal to 70% responses were “disagree or strongly disagree” and less than or equal to 15% responses were “agree or strongly agree” (consensus disagree).</p></div><div><h3>Results</h3><p>The top three qualities for defining MIST were minimal blood loss (<em>n</em>=466, 80.3%), fast post-operative recovery (<em>n</em>=431, 74.3%), and short hospital stay (<em>n</em>=425, 73.3%). The top three surgeries that were regarded as MIST were Urolift® (<em>n</em>=361, 62.2%), Rezum® (<em>n</em>=351, 60.5%), and endoscopic enucleation of the prostate (EEP) (<em>n</em>=332, 57.2%). Consensus in the knowledge section was achieved for the superiority of Urolift®, Rezum®, and iTIND® over transurethral resection of the prostate with regard to blood loss, recovery, day surgery feasibility, and post-operative continence. Consensus in the attitudes section was achieved for the superiority of Urolift®, Rezum®, and iTIND® over transurethral resection of the prostate with regard to blood loss, recovery, and day surgery feasibility. Consensus on both sections was achieved for EEP as the option with the better symptoms and flow improvement, lower retreatment rate, and better suitable for prostate more than 80 mL.</p></div><div><h3>Conclusion</h3><p>Minimal blood loss, fast post-operative recovery, and short hospital stay were the most important qualities for defining MIST. Urolift®, Rezum®, and EEP were regarded as MIST by most urologists.</p></div>","PeriodicalId":46599,"journal":{"name":"Asian Journal of Urology","volume":"11 1","pages":"Pages 55-64"},"PeriodicalIF":2.4000,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S221438822200090X/pdfft?md5=1d0370646ce1dbb1bc027110cb07a160&pid=1-s2.0-S221438822200090X-main.pdf","citationCount":"0","resultStr":"{\"title\":\"Defining minimal invasive surgical therapy for benign prostatic obstruction surgery: Perspectives from a global knowledge, attitude, and practice survey\",\"authors\":\"Bryan Kwun-Chung Cheng , Steffi Kar-Kei Yuen , Daniele Castellani , Marcelo Langer Wroclawski , Hongda Zhao , Mallikarjuna Chiruvella , Wei-Jin Chua , Ho-Yee Tiong , Yiloren Tanidir , Jean de la Rosette , Enrique Rijo , Vincent Misrai , Amy Krambeck , Dean S. Elterman , Bhaskar K. Somani , Jeremy Yuen-Chun Teoh , Vineet Gauhar\",\"doi\":\"10.1016/j.ajur.2022.02.011\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Objective</h3><p>To scrutinize the definitions of minimal invasive surgical therapy (MIST) and to investigate urologists’ knowledge, attitudes, and practices for benign prostatic obstruction surgeries.</p></div><div><h3>Methods</h3><p>A 36-item survey was developed with a Delphi method. Questions on definitions of MIST and attitudes and practices of benign prostatic obstruction surgeries were included. Urologists were invited globally to complete the online survey. Consensus was achieved when more than or equal to 70% responses were “agree or strongly agree” and less than or equal to 15% responses were “disagree or strongly disagree” (consensus agree), or when more than or equal to 70% responses were “disagree or strongly disagree” and less than or equal to 15% responses were “agree or strongly agree” (consensus disagree).</p></div><div><h3>Results</h3><p>The top three qualities for defining MIST were minimal blood loss (<em>n</em>=466, 80.3%), fast post-operative recovery (<em>n</em>=431, 74.3%), and short hospital stay (<em>n</em>=425, 73.3%). The top three surgeries that were regarded as MIST were Urolift® (<em>n</em>=361, 62.2%), Rezum® (<em>n</em>=351, 60.5%), and endoscopic enucleation of the prostate (EEP) (<em>n</em>=332, 57.2%). Consensus in the knowledge section was achieved for the superiority of Urolift®, Rezum®, and iTIND® over transurethral resection of the prostate with regard to blood loss, recovery, day surgery feasibility, and post-operative continence. Consensus in the attitudes section was achieved for the superiority of Urolift®, Rezum®, and iTIND® over transurethral resection of the prostate with regard to blood loss, recovery, and day surgery feasibility. Consensus on both sections was achieved for EEP as the option with the better symptoms and flow improvement, lower retreatment rate, and better suitable for prostate more than 80 mL.</p></div><div><h3>Conclusion</h3><p>Minimal blood loss, fast post-operative recovery, and short hospital stay were the most important qualities for defining MIST. Urolift®, Rezum®, and EEP were regarded as MIST by most urologists.</p></div>\",\"PeriodicalId\":46599,\"journal\":{\"name\":\"Asian Journal of Urology\",\"volume\":\"11 1\",\"pages\":\"Pages 55-64\"},\"PeriodicalIF\":2.4000,\"publicationDate\":\"2024-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.sciencedirect.com/science/article/pii/S221438822200090X/pdfft?md5=1d0370646ce1dbb1bc027110cb07a160&pid=1-s2.0-S221438822200090X-main.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Asian Journal of Urology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S221438822200090X\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"UROLOGY & NEPHROLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Asian Journal of Urology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S221438822200090X","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}
Defining minimal invasive surgical therapy for benign prostatic obstruction surgery: Perspectives from a global knowledge, attitude, and practice survey
Objective
To scrutinize the definitions of minimal invasive surgical therapy (MIST) and to investigate urologists’ knowledge, attitudes, and practices for benign prostatic obstruction surgeries.
Methods
A 36-item survey was developed with a Delphi method. Questions on definitions of MIST and attitudes and practices of benign prostatic obstruction surgeries were included. Urologists were invited globally to complete the online survey. Consensus was achieved when more than or equal to 70% responses were “agree or strongly agree” and less than or equal to 15% responses were “disagree or strongly disagree” (consensus agree), or when more than or equal to 70% responses were “disagree or strongly disagree” and less than or equal to 15% responses were “agree or strongly agree” (consensus disagree).
Results
The top three qualities for defining MIST were minimal blood loss (n=466, 80.3%), fast post-operative recovery (n=431, 74.3%), and short hospital stay (n=425, 73.3%). The top three surgeries that were regarded as MIST were Urolift® (n=361, 62.2%), Rezum® (n=351, 60.5%), and endoscopic enucleation of the prostate (EEP) (n=332, 57.2%). Consensus in the knowledge section was achieved for the superiority of Urolift®, Rezum®, and iTIND® over transurethral resection of the prostate with regard to blood loss, recovery, day surgery feasibility, and post-operative continence. Consensus in the attitudes section was achieved for the superiority of Urolift®, Rezum®, and iTIND® over transurethral resection of the prostate with regard to blood loss, recovery, and day surgery feasibility. Consensus on both sections was achieved for EEP as the option with the better symptoms and flow improvement, lower retreatment rate, and better suitable for prostate more than 80 mL.
Conclusion
Minimal blood loss, fast post-operative recovery, and short hospital stay were the most important qualities for defining MIST. Urolift®, Rezum®, and EEP were regarded as MIST by most urologists.
期刊介绍：
Asian Journal of Urology (AJUR), launched in October 2014, is an international peer-reviewed Open Access journal jointly founded by Shanghai Association for Science and Technology (SAST) and Second Military Medical University (SMMU). AJUR aims to build a communication platform for international researchers to effectively share scholarly achievements. It focuses on all specialties of urology both scientifically and clinically, with article types widely covering editorials, opinions, perspectives, reviews and mini-reviews, original articles, cases reports, rapid communications, and letters, etc. Fields of particular interest to the journal including, but not limited to: • Surgical oncology • Endourology • Calculi • Female urology • Erectile dysfunction • Infertility • Pediatric urology • Renal transplantation • Reconstructive surgery • Radiology • Pathology • Neurourology.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
